John Schieszer, MA

John Schieszer, MA is a freelance medical journalist. He holds a Masters of English degree from University of Missouri St. Louis and a Bachelor of Journalism degree from the University Of Missouri School Of Journalism, Columbia, Missouri.

Most Recent Articles by John Schieszer, MA

A Closer Look at Reporting Toxicities in Cancer Clinical Trials

A Closer Look at Reporting Toxicities in Cancer Clinical Trials

By

QoL for patients with cancer is reduced just as much by the accumulation of low-level toxicities as it is from high-level adverse events.

mTOR Inhibition May Benefit Some Sarcoma Patients

mTOR Inhibition May Benefit Some Sarcoma Patients

By

mTOR inhibition is thought to enhance the efficacy of chemotherapy.

Induction ILP Prior to Surgery for ESTS Did Not Improve Patient Outcomes Compared With Standard of Care

Induction ILP Prior to Surgery for ESTS Did Not Improve Patient Outcomes Compared With Standard of Care

By

The outcomes of patients with ESTS did not improve as a result of induction ILP prior to surgical intervention.

Fixed Duration of Venetoclax-Rituximab for CLL May Prolong Survival

Fixed Duration of Venetoclax-Rituximab for CLL May Prolong Survival

By

When used as a fixed-duration venetoclax-rituximab combination, 62% of patients achieved an undetectable minimal residual disease level in peripheral blood.

Analysis of Durvalumab Consolidation Therapy Costs in Stage III NSCLC

Analysis of Durvalumab Consolidation Therapy Costs in Stage III NSCLC

By

Use of durvalumab consolidation therapy in all eligible patients with NSCLC was deemed cost-effective, despite its incremental budgetary consequence of $768 million in year 1.

More Articles by John Schieszer, MA

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs